Lv1
32 积分 2025-11-08 加入
Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease
4个月前
已完结
Neurofilaments as biomarkers in neurological disorders — towards clinical application
9个月前
已完结
Biomarkers for amyotrophic lateral sclerosis
9个月前
已完结
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
9个月前
已完结
Comparison of CSF and plasma NfL and pNfH for Alzheimer’s disease diagnosis: a memory clinic study
9个月前
已完结
Glial fibrillary acidic protein: a blood biomarker to differentiate neurodegenerative from psychiatric diseases
9个月前
已关闭
Blood-based biomarkers for Alzheimer’s disease: a multicenter-based cross-sectional and longitudinal study in China
9个月前
已完结
Blood GFAP as an emerging biomarker in brain and spinal cord disorders
9个月前
已完结
Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years
9个月前
已完结
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
9个月前
已完结
皖公网安备34019202002308
